# vTv Therapeutics (VTVT) — News

VTVT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vtvt/news

## Recent headlines

- [Google built-in now spans 16 brands, 100+ car models](https://www.ainvest.com/news/google-built-spans-16-brands-100-car-models-2610) — AInvest Wire, Oct 13, 2026
  Google's integration of its Android-based infotainment system into the automotive industry has expanded significantly, now spanning 16 car brands and over 100 vehicle models. This development marks a major milestone in the company's strategy to establish a dominant presence in the connected car…
- [AdvancedAdvt Ltd: Hy trading remains in line with management expectations](https://www.ainvest.com/news/advancedadvt-hy-trading-remains-line-management-expectations-2610) — AInvest Wire, Oct 12, 2026
  AdvancedAdvt Ltd (ADVT) continues to report trading performance consistent with management expectations, with no significant deviations noted in recent operations. The company recently completed a share buyback of 243,453 shares , reflecting its ongoing commitment to managing capital structure and…
- [VTV Therapeutics announces inducement grants under Nasdaq listing rule 5635(C)(4)](https://www.ainvest.com/news/vtv-therapeutics-announces-inducement-grants-nasdaq-listing-rule-5635-4-2609) — AInvest Wire, Sep 15, 2026
- [VTV Therapeutics, Inc.: H.C. Wainwright cuts target price to $42 from $45](https://www.ainvest.com/news/vtv-therapeutics-wainwright-cuts-target-price-42-45-2608) — AInvest Wire, Aug 6, 2026
- [VTV Therapeutics Inc: BTIG raises target price to $57 from $49](https://www.ainvest.com/news/vtv-therapeutics-btig-raises-target-price-57-49-2607) — AInvest Wire, Jul 16, 2026
  BTIG has raised its price target for vTv Therapeutics Inc. (NASDAQ: VTVT) to $57 from $49, while maintaining its Buy rating on the stock. The firm highlighted the company’s broader pipeline potential beyond its lead diabetes program, cadisegliatin, which is currently in Phase 3 trials for Type 1…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).
